Kefei Dou
Impact in
-
- Acute Myocardial Infarction Research
- Cardiovascular Function and Risk Factors
-
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
- Surgery 43
- Coronary Interventions and Diagnostics 33
- Lipoproteins and Cardiovascular Health 8
-
- Acute Myocardial Infarction Research 19
- Antiplatelet Therapy and Cardiovascular Diseases 9
- Co-authors
- Chenxi Song (54 shared papers)Dong Yin (35 shared papers)Sheng Yuan (30 shared papers)Kongyong Cui (23 shared papers)Weihua Song (26 shared papers)Yuejin Yang (24 shared papers)Jining He (21 shared papers)Yanjun Song (21 shared papers)
- Journals
- Cardiovascular Diabetology (9 papers)BMJ Open (7 papers)Catheterization and Cardiovascular Interventions (7 papers)European Journal of Preventive Cardiology (5 papers)Diabetes Research and Clinical Practice (5 papers)
- Partner nations
- ChinaUnited StatesIreland
In The Last Decade
Kefei Dou
132 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 91
- Cardiology and Cardiovascular Medicine 325
- Endocrinology, Diabetes and Metabolism 188
- Radiology, Nuclear Medicine and Imaging 177
- Surgery 322
- Nephrology 32
Countries citing papers authored by Kefei Dou
This map shows the geographic impact of Kefei Dou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kefei Dou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kefei Dou more than expected).
Fields of papers citing papers by Kefei Dou
This network shows the impact of papers produced by Kefei Dou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kefei Dou. The network helps show where Kefei Dou may publish in the future.
Co-authors
The 25 scholars most cited alongside Kefei Dou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 146 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 77 | |
| 2 | 2022 | 49 | |
| 3 | 2008 | 48 | |
| 4 | 2023 | 45 | |
| 5 | 2022 | 43 | |
| 6 | 2020 | 41 | |
| 7 | 2023 | 41 | |
| 8 | 2019 | 37 | |
| 9 | 2007 | 32 | |
| 10 | 2023 | 26 | |
| 11 | 2023 | 26 | |
| 12 | 2023 | 24 | |
| 13 | 2022 | 23 | |
| 14 | 2018 | 23 | |
| 15 | 2022 | 21 | |
| 16 | 2020 | 21 | |
| 17 | 2022 | 20 | |
| 18 | 2018 | 20 | |
| 19 | 2020 | 20 | |
| 20 | 2022 | 19 |
About Kefei Dou
Kefei Dou is a scholar working on Surgery, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 146 papers that have together received 1.3k indexed citations. Recurring topics across this work include Coronary Interventions and Diagnostics (33 papers), Acute Myocardial Infarction Research (19 papers), Cardiac Imaging and Diagnostics (14 papers), Antiplatelet Therapy and Cardiovascular Diseases (9 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (8 papers), Lipoproteins and Cardiovascular Health (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers) and Inflammatory Biomarkers in Disease Prognosis (7 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (325 citations), Endocrinology, Diabetes and Metabolism (188 citations), Radiology, Nuclear Medicine and Imaging (177 citations), Surgery (322 citations) and Nephrology (32 citations). Kefei Dou has collaborated with scholars based in China, United States and Ireland. Frequent co-authors include Chenxi Song, Dong Yin, Sheng Yuan, Kongyong Cui, Weihua Song, Yuejin Yang, Jining He, Yanjun Song, Cheng‐Gang Zhu and Rui Fu. Their work appears in journals such as Cardiovascular Diabetology, BMJ Open, Catheterization and Cardiovascular Interventions, European Journal of Preventive Cardiology and Diabetes Research and Clinical Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.